- Description
- 16 pages; 24 cm.
- Series Statement
- Report / 116th Congress, 2d session, House of Representatives ; 116-513
- United States. Congress. House. Report ; 116-513.
- Subject
- Genre/Form
- Legislative materials.
- Note
- "September 17, 2020."
- Shipping list no.: 2021-0178-M.
- Bibliography (note)
- Includes bibliographical references.
- Reproduction (note)
- Call Number
- GPO Microfiche Y 1.1/8:116-513
- OCLC
- marcive1302202545
- Author
United States. Congress. House. Committee on Energy and Commerce, author.
- Title
National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2020 : report (to accompany H.R. 4866).
- Publisher
[Washington, D.C.] : [U.S. Government Publishing Office], [2020]
- Type of Content
text
- Type of Medium
microform
- Type of Carrier
microfiche
- Series
Report / 116th Congress, 2d session, House of Representatives ; 116-513
United States. Congress. House. Report ; http://id.loc.gov/authorities/names/n42025618 116-513.
- Bibliography
Includes bibliographical references.
- Reproduction
Microfiche. [Washington, D.C.] : U.S. Government Publishing Office, [2022] 1 microfiche : negative.
- Other Form:
Print version: United States. Congress. House. Committee on Energy and Commerce. National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2020 (OCoLC)1227101419
Online version: United States. Congress. House. Committee on Energy and Commerce. National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2020 (OCoLC)1227101459
- Gpo Item No.
1008-D (MF)
- Sudoc No.
Y 1.1/8:116-513